Diffusion Pharmaceuticals Inc. DFFN

Set alert

Price alert · DFFN

All alert types
4.40 +4.40 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
6.30M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.42
Beta
1.77
Short ratio
0.16
Inst. own
9.32%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2023
50-d avg
3.66
200-d avg
5.05
1y target
40.00

6M chart

Chart tools
Interval

Events in this range
  • Apr 3, 2023Earnings: —; estimate -2.2; surprise —%
  • Aug 8, 2023Earnings: —; estimate 0; surprise —%
Signals (21)
NameDateAgo
SMA: BullishAug 15, 20233 years ago
RSI: OverboughtAug 15, 20233 years ago
SMA: BullishAug 10, 20233 years ago
MACD: Buy SignalJul 17, 20233 years ago
RSI: OversoldJul 3, 20233 years ago
MACD: Sell SignalJun 27, 20233 years ago
MACD: Buy SignalJun 16, 20233 years ago
MACD: Sell SignalJun 5, 20233 years ago
MACD: Buy SignalApr 14, 20233 years ago
RSI: OversoldMar 28, 20233 years ago
SMA: BearishMar 22, 20233 years ago
SMA: BearishMar 13, 20233 years ago
MACD: Sell SignalMar 13, 20233 years ago
SMA: BullishMar 10, 20233 years ago
SMA: BearishMar 9, 20233 years ago
MACD: Buy SignalMar 7, 20233 years ago
SMA: BullishMar 2, 20233 years ago
SMA: BullishMar 1, 20233 years ago
SMA: BearishFeb 28, 20233 years ago
SMA: BearishFeb 21, 20233 years ago

Newest 20 of 21.

Analyst view

Consensus: buy

Buy
Price target (mean) 40.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DFFN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.00-2.000.0%00.0%0
Next quarter0.000.00 – 0.00-2.220.0%00.0%0
Current year0.000.00 – 0.000.000.0%00.0%0
Next year0.000.00 – 0.000.000.0%00.0%0

Upgrades and downgrades

The latest rating changes

DFFN analyst upgrades and downgrades
DateFirmActionFromTo
Aug 16, 2022HC Wainwright & Co.UpgradeNeutralBuy
Nov 25, 2020H.C. WainwrightReiterated—Buy
Nov 25, 2020H.C. WainwrightInitiated—Buy
Nov 17, 2020HC Wainwright & Co.DowngradeBuyNeutral
Nov 17, 2020H.C. WainwrightDowngradeBuyNeutral